2023

Tofacitinib vs oral prednisolone in moderately active UC

Ferric carboxymaltose vs Ferrous fumarate in Anemic children with IBD

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

Ritlecitinib and Brepocitinib in UC

Ustekinumab vs Infliximab in CD

Diverting ileostomy closure after pouch construction

Infliximab or azathioprine withdrawal in CD

Tofacitinib in acute severe ulcerative colitis

Allopurinol-thiopurine versus standard thiopurine in patients with IBD

Upadacitinib maintenance in moderate-severe UC